- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04736342
Patients Acceptance Towards Elective Labor in Induction (PALI) (PALI)
Patients Acceptance Towards Elective Induction of Labor at 39th Week of Gestation (PALI)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A normal pregnancy lasts between 37+0 to 41+6 weeks. Estimated date of delivery is set exactly at 40+0 weeks of gestation. Base on this estimation, professional society's guidelines have recommended to start inducing the labor from 41+0 to 41+6 weeks after the last menstrual period. Clinical practice during the last few decades has been moving towards this trend and postponing labor induction.
But is 40 weeks' gestational age the optimal endpoint of human pregnancy? Recent studies, however, showed different results where many of them support induction of labor at 39 weeks. A large cohort retrospective study which included information from merely 5.4 million non-anomalous live births in the United States from 2012 to 2016, though only modestly, the authors have been able to conclude that the rates of composite neonatal and maternal adverse outcomes increase from 39 through 41 weeks of gestation among low-risk parous women. Stratifying by parity, it seemed that the trend is also similar among all low-risk women no matter which parities they are in. When it comes to nulliparous women, results from a large prospective randomized control trial (the ARRIVE trial) show that induction of labor at 39 weeks in low-risk nulliparous women did not lead to significant lower frequency of a composite adverse perinatal outcome but it did result in a significant lower rate of cesarean delivery. More recently, in a review sponsored by the Cochrane library on induction of labor beyond 37 weeks' gestation has found that there is a clear reduction in perinatal death with a policy of labor induction at or beyond 37 weeks compared with expectant management, though absolute rates are small (0.4 versus 3 deaths per 1000). There were also lower caesarean rates without increasing rates of operative vaginal births and there were fewer Neonatal Intensive Care Unit admissions with a policy of induction. Base on these evidence, the American College of Obstetricians and Gynecologists has suggested "it's time to induce of labor at 39th week of gestation". It is true that although induction of labor is familiar with obstetricians, the procedure is still raising concern from patients' side. Even in the United States where patients consulting has been routinely applied, the rate of patients refuse to be induced at 39th week of gestation is about 50%. Review from Cochrane library also suggested that "Offering women tailored counselling may help them make an informed choice between induction of labor for pregnancies" . In some countries where the National Guidelines still recommends induction of labor should be considered after 41 weeks of gestation and pregnancy related decisions are driven by many identical factors such as: knowledge, traditional or cultural ones, the patients' perspective on induction of labor before 40 weeks of gestation is a challenge. Thus, the patients' understanding of the elective induction of labor and factors contribute to decision-making process towards induction of labor should be investigated in order not only to develop appropriate induction policies for the future but also scientific studies/randomized clinical trials to come.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Hà Nội
-
Hanoi, Hà Nội, Vietnam, 10000
- Hanoi Obstetrics and Gynecology Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Maternal age ≥ 18
- Singleton pregnancy (twin gestation reduced to singleton, either spontaneously or therapeutically, is not eligible unless the reduction occurred before 14 weeks project gestational age)
- Gestational age at 36+0 weeks to 36+6 week
- Cephalic presentation
- No contraindications to vaginal delivery
Exclusion Criteria:
- Previous C-section
- Maternal medical illness associated with increased risk of adverse pregnancy outcome (any diabetes mellitus, any hypertensive disorders, cardiac diseases, renal insufficiency, systemic lupus erythematosus, mental disorders, HIV positive, use of heparin or low-molecular weight heparin during the current pregnancy etc.)
- Abnormal placenta: Active vaginal bleeding greater than bloody show or placenta previa, accreta or vasa previa
Abnormal amniotic fluid volume:
Oligohydramnios (MVP < 2cm) Polyhydramnios (MVP > 10cm)
- Abnormal fetus Fetal demise or known major fetal anomalies Fetal growth restriction (FGR) (EFW < 3% or < 10% and abnormal Doppler) Non-reassuring fetal status (no fetal movements, abnormal fetal heart rate at auscultation)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of patients accept to undergo elective induction of labor at 39th gestational week
Time Frame: It is planned to fill the questionnaire in 30 minutes at 39th gestational week
|
Number of patients who are willing to undergo elective Induction of labor without maternal of fetal indication at 39th gestational week
|
It is planned to fill the questionnaire in 30 minutes at 39th gestational week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participants knowledge
Time Frame: It is planned to fill the questionnaire in 30 minutes at 36th gestational week
|
Description of knowledge and opinions of participants towards induction of labor The knowledge about induction of labor, consisted of 13 multiple choice questions including different methods, indications, contraindications, maternal and fetal benefits/ risks of induction of labor.
|
It is planned to fill the questionnaire in 30 minutes at 36th gestational week
|
Participants opinions
Time Frame: It is planned to fill the questionnaire in 30 minutes at 36th gestational week
|
Opinion about the needs for induction of labor, consisted of 12 questions including different reasons for labor induction.
Participants choose the level of agreement (strongly disagree; disagree; support; strongly support) for each questions.
|
It is planned to fill the questionnaire in 30 minutes at 36th gestational week
|
Reasons to choose or refuse elective induction of labor at 36th gestational week
Time Frame: It is planned to fill the questionnaire in 30 minutes at 36th gestational week
|
Reasons why participants choose or refuse elective induction of labor: a checklist (yes/no) of 14 reasons and an open-end question
|
It is planned to fill the questionnaire in 30 minutes at 36th gestational week
|
Reason why participants change initial decision about elective induction of labor
Time Frame: It is planned to fill the questionnaire in 30 minutes at 39th gestational week
|
Reason why participants change decision about elective induction of labor: a checklist (yes/no) of 14 reasons and an open-end question
|
It is planned to fill the questionnaire in 30 minutes at 39th gestational week
|
Factors that may affect participants' decision
Time Frame: It is planned to fill the questionnaire in 30 minutes at 36th gestational week
|
Factors that may affect participants' decision towards elective induction of labor: multiple choice questions regarding the age, ethnic group, education background, profession, financial ability, residential and cohabitation arrangement, healthcare preferences of participants
|
It is planned to fill the questionnaire in 30 minutes at 36th gestational week
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Ha Nguyen Thi Thu, PhD. MD, Hanoi Obstetric and Gynecology Hospital
- Principal Investigator: Minh Chau Ngoc, MD, Mỹ Đức Hospital
Publications and helpful links
General Publications
- ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-397. doi: 10.1097/AOG.0b013e3181b48ef5. No abstract available.
- Chen HY, Grobman WA, Blackwell SC, Chauhan SP. Neonatal and Maternal Adverse Outcomes Among Low-Risk Parous Women at 39-41 Weeks of Gestation. Obstet Gynecol. 2019 Aug;134(2):288-294. doi: 10.1097/AOG.0000000000003372.
- Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566.
- Gallagher PJ, Liveright E, Mercier RJ. Patients' perspectives regarding induction of labor in the absence of maternal and fetal indications: are our patients ready for the ARRIVE trial? Am J Obstet Gynecol MFM. 2020 May;2(2):100086. doi: 10.1016/j.ajogmf.2020.100086. Epub 2020 Jan 12.
- Middleton P, Shepherd E, Morris J, Crowther CA, Gomersall JC. Induction of labour at or beyond 37 weeks' gestation. Cochrane Database Syst Rev. 2020 Jul 15;7(7):CD004945. doi: 10.1002/14651858.CD004945.pub5.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PSHN.0002.2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Acceptance of Health Care
-
Malahat AmaniCompletedPatient Acceptance of Health CareIran, Islamic Republic of
-
Cairo UniversityUnknown
-
Cukurova UniversityNot yet recruitingPatient Acceptance of Health Care | Drug Compliance
-
Nepal Mediciti HospitalCompletedSafety Issues | Patient Acceptance of Health CareNepal
-
Chiang Mai UniversityCompleted
-
University of ChicagoNational Institute of Mental Health (NIMH); ACCESS Community Health NetworkCompletedHIV | Patient Acceptance of Health CareUnited States
-
Medstar Health BaltimoreRecruitingHeart Failure | Patient Acceptance of Health CareUnited States
-
Fudan UniversityMerck Sharp & Dohme LLCWithdrawnData Collection | Machine Learning | Patient Acceptance of Health Care | Vaccination Refusal | Internet-Based Intervention | Immunization Programs | Information Dissemination | Social Medium
-
Cliniques universitaires Saint-Luc- Université...UnknownSkin Cancer | Patient Satisfaction | Patient Acceptance of Health Care
-
University of BernRecruitingTooth Loss | Patient Satisfaction | Patient Acceptance of Health Care | Bone Graft; ComplicationsSwitzerland
Clinical Trials on PALI questionaire
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; University of ChicagoRecruitingBladder Cancer | Urothelial Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
Sygehus LillebaeltKolding SygehusCompleted
-
University Hospital Inselspital, BerneCompletedSexual Orientation | Family CharacteristicsSwitzerland
-
Fayoum UniversityCompleted
-
The Cleveland ClinicUnknownSleep Apnea | Adverse EventUnited States
-
Hospices Civils de LyonCompletedAnoxic-Ischemic EncephalopathyFrance
-
Hillel Yaffe Medical CenterCompletedConditions Influencing Health StatusIsrael
-
Eurofertil IVF Health CenterCompletedStress | PregnancyTurkey
-
Zurich University of Applied SciencesCompleted